ATE250600T1 - Optische spaltung von 1-azabicylo(2.2.2)octan-3- amin,2-(diphenylmethyl)-n-((2-methoxy-5-(1- methylethyl)phenyl)methyl) - Google Patents

Optische spaltung von 1-azabicylo(2.2.2)octan-3- amin,2-(diphenylmethyl)-n-((2-methoxy-5-(1- methylethyl)phenyl)methyl)

Info

Publication number
ATE250600T1
ATE250600T1 AT96918801T AT96918801T ATE250600T1 AT E250600 T1 ATE250600 T1 AT E250600T1 AT 96918801 T AT96918801 T AT 96918801T AT 96918801 T AT96918801 T AT 96918801T AT E250600 T1 ATE250600 T1 AT E250600T1
Authority
AT
Austria
Prior art keywords
azabicylo
diphenylmethyl
methylethyl
octane
methoxy
Prior art date
Application number
AT96918801T
Other languages
English (en)
Inventor
Derek L Tickner
Morgan Meltz
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE250600T1 publication Critical patent/ATE250600T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
AT96918801T 1995-07-17 1996-07-04 Optische spaltung von 1-azabicylo(2.2.2)octan-3- amin,2-(diphenylmethyl)-n-((2-methoxy-5-(1- methylethyl)phenyl)methyl) ATE250600T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US119195P 1995-07-17 1995-07-17
PCT/IB1996/000648 WO1997003984A1 (en) 1995-07-17 1996-07-04 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]

Publications (1)

Publication Number Publication Date
ATE250600T1 true ATE250600T1 (de) 2003-10-15

Family

ID=21694832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918801T ATE250600T1 (de) 1995-07-17 1996-07-04 Optische spaltung von 1-azabicylo(2.2.2)octan-3- amin,2-(diphenylmethyl)-n-((2-methoxy-5-(1- methylethyl)phenyl)methyl)

Country Status (25)

Country Link
US (1) US6008357A (de)
EP (1) EP0840735B1 (de)
JP (1) JP3043074B2 (de)
KR (1) KR100276989B1 (de)
CN (1) CN1068598C (de)
AR (1) AR002772A1 (de)
AT (1) ATE250600T1 (de)
AU (1) AU697553B2 (de)
CA (1) CA2227194C (de)
CO (1) CO4480720A1 (de)
CZ (1) CZ15098A3 (de)
DE (1) DE69630123T2 (de)
DK (1) DK0840735T3 (de)
ES (1) ES2205039T3 (de)
HU (1) HUP9900238A3 (de)
IL (1) IL122655A0 (de)
MY (1) MY115734A (de)
NO (1) NO980211L (de)
NZ (1) NZ310539A (de)
PE (1) PE8798A1 (de)
PL (1) PL184261B1 (de)
PT (1) PT840735E (de)
RU (1) RU2136681C1 (de)
WO (1) WO1997003984A1 (de)
ZA (1) ZA966026B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL210065B1 (pl) * 2002-09-25 2011-11-30 Memory Pharm Corp Związki indazole, benzotiazole i benzoizotiazole, kompozycje farmaceutyczne je zawierające oraz zastosowanie związków
US6861526B2 (en) 2002-10-16 2005-03-01 Pfizer Inc. Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
BRPI0507334A (pt) * 2004-02-02 2007-07-03 Pfizer Prod Inc processo para a preparação de -1(2s,3s)-2-benzidril-n-(5-terc-butil-2-metoxibenzila)q uinuclidin-3-amina
US20060100438A1 (en) * 2004-11-10 2006-05-11 Boehringer Ingelheim Chemicals, Inc. Process of making fentanyl intermediates
JP2012511585A (ja) * 2008-12-09 2012-05-24 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイテッド キナーゼ阻害化合物
US20160332962A1 (en) 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CN108341812A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 一种含奎宁环化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
NO168529C (no) * 1989-09-15 1992-03-04 Chiron Lab As Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
FI935134A7 (fi) * 1991-05-22 1993-11-19 Pfizer Substituoidut 3-aminokinuklidiinit
DE9290063U1 (de) * 1991-05-31 1994-02-24 Pfizer Inc., New York, N.Y. Chinuclidin-Derivate
US5604241A (en) * 1992-10-21 1997-02-18 Pfizer Inc. Substituted benzylaminoquinuclidines as substance P antagonists

Also Published As

Publication number Publication date
DK0840735T3 (da) 2004-02-09
DE69630123T2 (de) 2004-04-08
MY115734A (en) 2003-08-30
ES2205039T3 (es) 2004-05-01
EP0840735A1 (de) 1998-05-13
CN1068598C (zh) 2001-07-18
WO1997003984A1 (en) 1997-02-06
MX9800538A (es) 1998-05-31
RU2136681C1 (ru) 1999-09-10
NO980211D0 (no) 1998-01-16
ZA966026B (en) 1998-01-16
HUP9900238A2 (hu) 1999-05-28
PT840735E (pt) 2004-02-27
NO980211L (no) 1998-03-16
PL324610A1 (en) 1998-06-08
KR19990029058A (ko) 1999-04-15
CA2227194C (en) 2002-02-12
CA2227194A1 (en) 1997-02-06
EP0840735B1 (de) 2003-09-24
NZ310539A (en) 1998-11-25
HK1010195A1 (en) 1999-06-17
CO4480720A1 (es) 1997-07-09
CZ15098A3 (cs) 1999-02-17
DE69630123D1 (en) 2003-10-30
HUP9900238A3 (en) 2001-08-28
PE8798A1 (es) 1998-03-02
AU6134896A (en) 1997-02-18
JP3043074B2 (ja) 2000-05-22
US6008357A (en) 1999-12-28
CN1190970A (zh) 1998-08-19
JPH10511102A (ja) 1998-10-27
AR002772A1 (es) 1998-04-29
PL184261B1 (pl) 2002-09-30
KR100276989B1 (ko) 2001-01-15
IL122655A0 (en) 1998-08-16
AU697553B2 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
FI933804A0 (fi) Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2h-indol-2-onkhydroklorid
DE69226449D1 (de) 2-(2,6-difluorphenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-axazoline
DE122012000017I1 (de) Neuartige form von s-omeprazol.
PT907650E (pt) N-¬4-(heteroarilmetil)fenil|heteroarilaminasc
BR9605906A (pt) Compostos benzo-heterociclicos substituídos por aminoalquila utilizaçao processo para sua fabricaçao e agentes com açao antimicótica e redutora do colesterol contendo os mesmos
DK0712304T3 (da) Vævmaterialer, der udviser elastiklignende adfærd
DZ1966A1 (fr) Combinaison pharmaceutique nouvelle.
FI974363A7 (fi) 2-(1H-4(5)-imidatsoyyli)syklopropyylijohdannaiset
ID16867A (id) Garam-garam dihidrat mesilat 5-(2-(4-1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-kloro-1,3-dihidro-2h-indol-2-on
NO964950L (no) Krystallinsk hydroklorid av (R)-(-)-2-{N-£4-(1,1-dioksido-3-okso-2,3-dihydro-benziso-tiazol-2-yl)-butyl|-aminometyl}-kroman
BR9608155A (pt) Amino fenil uracilas substituídas
FI953592L (fi) 2-(2-amino-1,6-dihydro-6-oksopurin-9-yyli)metoksi-1,3-propaanidiolijohdannainen
FI972946L (fi) Uudet metalloseeniyhdisteet etyleenisesti tyydyttämätt"mien monomeerien polymeroimiseksi
NO180445C (no) 2-(4-hydroksypiperidino)-1-alkanol-derivater som anti-iskemiske midler
DE69820558D1 (de) Optisch gepumpter Laser
DE59801792D1 (de) Kristallform von N-(4-Trifluormethylphenyl)-5-methylisoxazol-4-carbonsäureamid
BR9305533A (pt) Processo enzimático para a preparação de N-Hexanol, 3-(Z)-Hexen-1-al ou 2-(E)-Hexen -1-al
DE69600673D1 (de) Optischer Duplexer
PT981525E (pt) Novos intermediarios e processo para a sua preparacao
MA23779A1 (fr) Compose 9-substitue 2-(2-n-alkoxyphenyl) - purine -6- ones
ATE250600T1 (de) Optische spaltung von 1-azabicylo(2.2.2)octan-3- amin,2-(diphenylmethyl)-n-((2-methoxy-5-(1- methylethyl)phenyl)methyl)
NO973508L (no) Antipsykotiske 4-(1H-indol-l-yl)-piperidinylderivater
DE59609043D1 (de) Feste Lösungen von 1,4-Diketopyrrolopyrrolen
DE69918888D1 (de) Optische Abtastung von Dokumenten
IT1274571B (it) Procedimento per la preparazione di ¬r-(r*,r*)|-5-(3-clorofenil)-3- ¬2-(3,4-dimetossifenil)-1-metil-etil|-ossazolidin-2-one

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0840735

Country of ref document: EP

REN Ceased due to non-payment of the annual fee